[Three Cases of Moyamoya Disease with a History of Kawasaki Disease]

Toshinari Kawasaki1, Yoshiki Arakawa, Toshiya Sugino

  • 1Department of Neurosurgery, Kyoto University School of Medicine.

Insights

This study highlights three cases of moyamoya disease in patients with a history of Kawasaki disease, emphasizing the potential link and the need for vigilance in monitoring neurological symptoms. Early detection and intervention are crucial for managing this rare cerebrovascular condition.

Area of Science:

  • Neurology
  • Pediatrics
  • Vascular Surgery

Background:

  • Moyamoya disease is a rare, progressive cerebrovascular disorder characterized by stenosis or occlusion of the terminal internal carotid arteries (ICAs) and the development of collateral vessels.
  • Kawasaki disease is an acute febrile illness that can affect blood vessels, including coronary arteries, but its association with moyamoya disease is less commonly reported.

Observation:

  • Three pediatric and adult cases are presented, all with a documented history of Kawasaki disease treated with immunoglobulin or aspirin.
  • Patients presented with varying neurological symptoms, including headache, lisping, and epilepsy, alongside diagnosed moyamoya disease.
  • Diagnostic imaging revealed stenotic lesions in the ICAs, with some cases showing progression of stenosis and cerebral blood flow impairment over time.

Findings:

  • The cases suggest a potential association between Kawasaki disease and the development of moyamoya disease, particularly in individuals with a history of this childhood illness.
  • Despite initial mild or absent ischemic lesions on MRI, angiography confirmed significant ICA stenosis in all reported cases.
  • Surgical interventions, including encephaloduroarteriosynangiosis and bilateral direct bypass, were performed in response to worsening symptoms and progressing disease.

Implications:

  • This report underscores the importance of considering moyamoya disease in patients with a history of Kawasaki disease, especially those presenting with neurological deficits.
  • Further research is warranted to elucidate the underlying mechanisms connecting Kawasaki disease and moyamoya disease.
  • Enhanced surveillance and timely neurovascular assessment may be beneficial for individuals with a history of Kawasaki disease to detect and manage moyamoya disease effectively.

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.3K
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
856
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
960
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
447
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.0K
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
463